艾昆緯-加速健康公平:挑戰(zhàn)與機(jī)遇(英)-2024-WN8_第1頁
艾昆緯-加速健康公平:挑戰(zhàn)與機(jī)遇(英)-2024-WN8_第2頁
艾昆緯-加速健康公平:挑戰(zhàn)與機(jī)遇(英)-2024-WN8_第3頁
艾昆緯-加速健康公平:挑戰(zhàn)與機(jī)遇(英)-2024-WN8_第4頁
艾昆緯-加速健康公平:挑戰(zhàn)與機(jī)遇(英)-2024-WN8_第5頁
已閱讀5頁,還剩49頁未讀 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)

文檔簡介

AccHea

CHALLENG

Highlights

hostedbyt

AUGUST

2024

Tableofcontents

Participants

Introduction

Wherehave

Howdowem

Whatarethe

equityinitia

Continuedco

AbouttheIn

REFERENCINGTHISRE

Pleaseusethisformat

Source:IQVIAInstitutef

Availablefromwww.iqvi

?2024IQVIAanditsa?lia

transmittedinanyformo

expresswrittenconsento

AcceleratingHealthEquity:ChallengesandOpportunities

Participantandmoderators

SéRGIOALVES,MBA

AstraZeneca

CLEONRICE,MBA

Genentech

BINTABEARD,D.SC.,MS

Novartis

XAVIORROBINSON,MHSA

Merck

PATRICIADOYKOS,PH.D.

BristolMyersSquibb

JAYG.RONQUILLO,MD,MPH,MMSc,

MEng

P?zer

MAUREENDOYLE-SCHARFF,PH.D.

P?zer

DEBBIESMITH,PH.D.

UCB

IVYKAM,PHARMD

Regeneron

JUDITHTHOMPSON,PHARMD,MPH,

CPHQ

UCB

SHELINARAMNARINE,PH.D.

Johnson&Johnson

Moderators

MURRAYAITKEN

ExecutiveDirector,

IQVIAInstituteforHuman

DataScience

Murray.Aitken@IQVIAI

ELIZASILVESTER

SeniorPrincipal,

EnterpriseTransformationStrategy,

IQVIA

Eliza.Silvester@

|1

Introduction

Achievinghealthequityisanimportantpriorityfor

thehealthcareecosystem,especiallythelifesciences

Wherehaveweachieved

successtowardhealthequity

andhow?

industry.Theindustryhasmadedeclarationsabout

itscommitmenttoaddressdisparitiesinR&D,clinical

development,andaccesstocare,andmanyorganizations

Thehealthequitylandscapeisever-evolving,withtwo

majorin?ectionpointssince2020:

haveestablisheddedicatedteamsandfunctionsto

advancehealthequity;however,achievinghealthequity

iscomplexandchallenging,andthereisuncertainty

abouthowtomeasureanddeliversustainedprogressin

arapidlyevolving?eld.

?Aspotlightonthehealthequitylandscape:

ThepandemicandthemurderofGeorgeFloydin

2020becamein?ectionpointsforawide-ranging

movementtoaddresshealthdisparitiesand

inequitiesforvulnerableandill-servedpopulations.

Toaddressthechallengesandopportunitiesaround

Manyorganizationsandcompaniesembarkedona

healthequity,theIQVIAInstituteconvenedalifesciences

journeytoaddresstheissuesthroughcommitments

industryroundtableonApril18,2024.

anddeclarations,andmanyinvestedresourcesin

Theroundtablefocusedonthreeimportantquestions:

programsandpeople,includingthecreationofDEI

o?ces,teams,andfunctions.Successeshavebeen

?Wherehavewebeenabletoachievesuccesstoward

healthequity,andwhy?

achieved,buttherehavebeenchallengescreating

asustainableshifttowardhealthequity,both

amongintra-companyandexternalstakeholders.

?HowdowemeasuretheimpactandROIofhealth

Furthermore,therehasbeenashortageofevidence

equityinvestments?

oftheimpactofthee?orts.

?Whatarethegreatestchallenges,eitherinternalor

?BacklashagainstDEIandESG:Inthemorerecent

external,toadvancinghealthequityinitiativesandto

period,anewin?ectionpointappearstohaveemerged

addressingthesechallenges?

withagrowingbacklashtowardDEI(diversity,equity

Thefollowingsummaryprovideshighlightsfromthe

discussion.

andinclusion)andESG(environment,socialand

governance)broadlyatuniversities,ingovernments

andincorporationsaswell,inpartdrivenbythe

Thisroundtablewasconvenedasapublicservice

SupremeCourtdecisionregardinga?rmativeaction.

withoutexternalfundingandintendedtostimulate

discussionandacceleratehealthequity.

“Thein?ectionpointwastheCOVID-19pandemicandahandfulofother

thingsthatbroughtthewholeideaofhealthequityandhealthdisparities

totheforefront.”

2|AcceleratingHealthEquity:ChallengesandOpportunities

Despitebroadindustryconsensusaboutthedeep

Butactioninghealthequitycanbedi?cult:

structuralhealthinequitiesinsociety,manyleadersof

healthequityfunctionswithinthelifesciencesindustry

arenowfacedwithchallengestoadvancehealth

equity—bothinternallyandexternally.Therehave

beengrowingquestionsaboutthecommercialvalue

ofinvestmentsinDEIandrequestsfordemonstration

ofevidenceofthepositiveimpactonthea?ectedill-

servedpopulations.

?Fragmentationlimitssynergy:Manycurrenthealth

equityactivitiesarefragmented,andmanytimesthe

lefthanddoesnotknowwhattherighthandisdoing.

DEIleadershavefrequentlybeensuccessfulinbuilding

synergybyconnectingseparatedepartmentsthatare

strivingtowardthesameoutcomestoimprovethe

collectivee?ortsindiversity,inclusivityinresearch,

andaccesstomedicines.

Internally,thecallforhealthequityhasbeenheard:

?DedicatedDEIfunctionswithend-to-endoversight:

Theestablishmentoffull-timededicatedDEI

leadershippositionsandteamshasbeenacritical

“Alotoftimesthelefthand

prerequisiteforadvancinghealthequitypractices

withinlifesciencescompanies.Theabilityofthese

leaderstoworkacrosstheenterprisehasbeen

importanttostimulateend-to-endhealthequity

e?ortscross-functionally.

doesn’tknowwhattherighthand

isdoing.Onepartoftheorganization

couldbepartneringwitha

?Employeeresourcegroupsareimportantdrivers:

Theemployeeresourceteamsrepresentingthe

diversegroupsthatidentifywithmarginalizedminority

populationshavebeenpositivedriversofchange.

historicallyBlackmedicalschoolon

oneinitiative,maybeingenomic

researchdiversity.Andthenclinical

Whilethecompanies’ownemployeeslikelyarenot

experiencingthesamehardshipsastheexternal

marginalizedcommunities,theyarenevertheless

researchisgoingintothesame

school,notrealizingthatgenomic

importantconduitstounderstandthespeci?cneeds

ofthesecommunitiesastheycanassesswhether

programsandinterventionsresonate.

researchisalreadyintheretalking

aboutsomethingsimilar.”

“Engagingouremployeeresourcegroupsishelpingusthinkthroughour

healthequityandsciencediversitystrategiesandapproaches.”

|3

AccHea

CHALLENG

Highlights

hostedbyt

AUGUST

2024

Tableofcontents

Participants

Introduction

Wherehave

Howdowem

Whatarethe

equityinitia

Continuedco

AbouttheIn

REFERENCINGTHISRE

Pleaseusethisformat

Source:IQVIAInstitutef

Availablefromwww.iqvi

?2024IQVIAanditsa?lia

transmittedinanyformo

expresswrittenconsento

AcceleratingHealthEquity:ChallengesandOpportunities

Participantandmoderators

SéRGIOALVES,MBA

AstraZeneca

CLEONRICE,MBA

Genentech

BINTABEARD,D.SC.,MS

Novartis

XAVIORROBINSON,MHSA

Merck

PATRICIADOYKOS,PH.D.

BristolMyersSquibb

JAYG.RONQUILLO,MD,MPH,MMSc,

MEng

P?zer

MAUREENDOYLE-SCHARFF,PH.D.

P?zer

DEBBIESMITH,PH.D.

UCB

IVYKAM,PHARMD

Regeneron

JUDITHTHOMPSON,PHARMD,MPH,

CPHQ

UCB

SHELINARAMNARINE,PH.D.

Johnson&Johnson

Moderators

MURRAYAITKEN

ExecutiveDirector,

IQVIAInstituteforHuman

DataScience

Murray.Aitken@IQVIAI

ELIZASILVESTER

SeniorPrincipal,

EnterpriseTransformationStrategy,

IQVIA

Eliza.Silvester@

|1

Introduction

Achievinghealthequityisanimportantpriorityfor

thehealthcareecosystem,especiallythelifesciences

Wherehaveweachieved

successtowardhealthequity

andhow?

industry.Theindustryhasmadedeclarationsabout

itscommitmenttoaddressdisparitiesinR&D,clinical

development,andaccesstocare,andmanyorganizations

Thehealthequitylandscapeisever-evolving,withtwo

majorin?ectionpointssince2020:

haveestablisheddedicatedteamsandfunctionsto

advancehealthequity;however,achievinghealthequity

iscomplexandchallenging,andthereisuncertainty

abouthowtomeasureanddeliversustainedprogressin

arapidlyevolving?eld.

?Aspotlightonthehealthequitylandscape:

ThepandemicandthemurderofGeorgeFloydin

2020becamein?ectionpointsforawide-ranging

movementtoaddresshealthdisparitiesand

inequitiesforvulnerableandill-servedpopulations.

Toaddressthechallengesandopportunitiesaround

Manyorganizationsandcompaniesembarkedona

healthequity,theIQVIAInstituteconvenedalifesciences

journeytoaddresstheissuesthroughcommitments

industryroundtableonApril18,2024.

anddeclarations,andmanyinvestedresourcesin

Theroundtablefocusedonthreeimportantquestions:

programsandpeople,includingthecreationofDEI

o?ces,teams,andfunctions.Successeshavebeen

?Wherehavewebeenabletoachievesuccesstoward

healthequity,andwhy?

achieved,buttherehavebeenchallengescreating

asustainableshifttowardhealthequity,both

amongintra-companyandexternalstakeholders.

?HowdowemeasuretheimpactandROIofhealth

Furthermore,therehasbeenashortageofevidence

equityinvestments?

oftheimpactofthee?orts.

?Whatarethegreatestchallenges,eitherinternalor

?BacklashagainstDEIandESG:Inthemorerecent

external,toadvancinghealthequityinitiativesandto

period,anewin?ectionpointappearstohaveemerged

addressingthesechallenges?

withagrowingbacklashtowardDEI(diversity,equity

Thefollowingsummaryprovideshighlightsfromthe

discussion.

andinclusion)andESG(environment,socialand

governance)broadlyatuniversities,ingovernments

andincorporationsaswell,inpartdrivenbythe

Thisroundtablewasconvenedasapublicservice

SupremeCourtdecisionregardinga?rmativeaction.

withoutexternalfundingandintendedtostimulate

discussionandacceleratehealthequity.

“Thein?ectionpointwastheCOVID-19pandemicandahandfulofother

thingsthatbroughtthewholeideaofhealthequityandhealthdisparities

totheforefront.”

2|AcceleratingHealthEquity:ChallengesandOpportunities

Despitebroadindustryconsensusaboutthedeep

Butactioninghealthequitycanbedi?cult:

structuralhealthinequitiesinsociety,manyleadersof

healthequityfunctionswithinthelifesciencesindustry

arenowfacedwithchallengestoadvancehealth

equity—bothinternallyandexternally.Therehave

beengrowingquestionsaboutthecommercialvalue

ofinvestmentsinDEIandrequestsfordemonstration

ofevidenceofthepositiveimpactonthea?ectedill-

servedpopulations.

?Fragmentationlimitssynergy:Manycurrenthealth

equityactivitiesarefragmented,andmanytimesthe

lefthanddoesnotknowwhattherighthandisdoing.

DEIleadershavefrequentlybeensuccessfulinbuilding

synergybyconnectingseparatedepartmentsthatare

strivingtowardthesameoutcomestoimprovethe

collectivee?ortsindiversity,inclusivityinresearch,

andaccesstomedicines.

Internally,thecallforhealthequityhasbeenheard:

?DedicatedDEIfunctionswithend-to-endoversight:

Theestablishmentoffull-timededicatedDEI

leadershippositionsandteamshasbeenacritical

“Alotoftimesthelefthand

prerequisiteforadvancinghealthequitypractices

withinlifesciencescompanies.Theabilityofthese

leaderstoworkacrosstheenterprisehasbeen

importanttostimulateend-to-endhealthequity

e?ortscross-functionally.

doesn’tknowwhattherighthand

isdoing.Onepartoftheorganization

couldbepartneringwitha

?Employeeresourcegroupsareimportantdrivers:

Theemployeeresourceteamsrepresentingthe

diversegroupsthatidentifywithmarginalizedminority

populationshavebeenpositivedriversofchange.

historicallyBlackmedicalschoolon

oneinitiative,maybeingenomic

researchdiversity.Andthenclinical

Whilethecompanies’ownemployeeslikelyarenot

experiencingthesamehardshipsastheexternal

marginalizedcommunities,theyarenevertheless

researchisgoingintothesame

school,notrealizingthatgenomic

importantconduitstounderstandthespeci?cneeds

ofthesecommunitiesastheycanassesswhether

programsandinterventionsresonate.

researchisalreadyintheretalking

aboutsomethingsimilar.”

“Engagingouremployeeresourcegroupsishelpingusthinkthroughour

healthequityandsciencediversitystrategiesandapproaches.”

|3

AccHea

CHALLENG

Highlights

hostedbyt

AUGUST

2024

Tableofcontents

Participants

Introduction

Wherehave

Howdowem

Whatarethe

equityinitia

Continuedco

AbouttheIn

REFERENCINGTHISRE

Pleaseusethisformat

Source:IQVIAInstitutef

Availablefromwww.iqvi

?2024IQVIAanditsa?lia

transmittedinanyformo

expresswrittenconsento

AcceleratingHealthEquity:ChallengesandOpportunities

Participantandmoderators

SéRGIOALVES,MBA

AstraZeneca

CLEONRICE,MBA

Genentech

BINTABEARD,D.SC.,MS

Novartis

XAVIORROBINSON,MHSA

Merck

PATRICIADOYKOS,PH.D.

BristolMyersSquibb

JAYG.RONQUILLO,MD,MPH,MMSc,

MEng

P?zer

MAUREENDOYLE-SCHARFF,PH.D.

P?zer

DEBBIESMITH,PH.D.

UCB

IVYKAM,PHARMD

Regeneron

JUDITHTHOMPSON,PHARMD,MPH,

CPHQ

UCB

SHELINARAMNARINE,PH.D.

Johnson&Johnson

Moderators

MURRAYAITKEN

ExecutiveDirector,

IQVIAInstituteforHuman

DataScience

Murray.Aitken@IQVIAI

ELIZASILVESTER

SeniorPrincipal,

EnterpriseTransformationStrategy,

IQVIA

Eliza.Silvester@

|1

Introduction

Achievinghealthequityisanimportantpriorityfor

thehealthcareecosystem,especiallythelifesciences

Wherehaveweachieved

successtowardhealthequity

andhow?

industry.Theindustryhasmadedeclarationsabout

itscommitmenttoaddressdisparitiesinR&D,clinical

development,andaccesstocare,andmanyorganizations

Thehealthequitylandscapeisever-evolving,withtwo

majorin?ectionpointssince2020:

haveestablisheddedicatedteamsandfunctionsto

advancehealthequity;however,achievinghealthequity

iscomplexandchallenging,andthereisuncertainty

abouthowtomeasureanddeliversustainedprogressin

arapidlyevolving?eld.

?Aspotlightonthehealthequitylandscape:

ThepandemicandthemurderofGeorgeFloydin

2020becamein?ectionpointsforawide-ranging

movementtoaddresshealthdisparitiesand

inequitiesforvulnerableandill-servedpopulations.

Toaddressthechallengesandopportunitiesaround

Manyorganizationsandcompaniesembarkedona

healthequity,theIQVIAInstituteconvenedalifesciences

journeytoaddresstheissuesthroughcommitments

industryroundtableonApril18,2024.

anddeclarations,andmanyinvestedresourcesin

Theroundtablefocusedonthreeimportantquestions:

programsandpeople,includingthecreationofDEI

o?ces,teams,andfunctions.Successeshavebeen

?Wherehavewebeenabletoachievesuccesstoward

healthequity,andwhy?

achieved,buttherehavebeenchallengescreating

asustainableshifttowardhealthequity,both

amongintra-companyandexternalstakeholders.

?HowdowemeasuretheimpactandROIofhealth

Furthermore,therehasbeenashortageofevidence

equityinvestments?

oftheimpactofthee?orts.

?Whatarethegreatestchallenges,eitherinternalor

?BacklashagainstDEIandESG:Inthemorerecent

external,toadvancinghealthequityinitiativesandto

period,anewin?ectionpointappearstohaveemerged

addressingthesechallenges?

withagrowingbacklashtowardDEI(diversity,equity

Thefollowingsummaryprovideshighlightsfromthe

discussion.

andinclusion)andESG(environment,socialand

governance)broadlyatuniversities,ingovernments

andincorporationsaswell,inpartdrivenbythe

Thisroundtablewasconvenedasapublicservice

SupremeCourtdecisionregardinga?rmativeaction.

withoutexternalfundingandintendedtostimulate

discussionandacceleratehealthequity.

“Thein?ectionpointwastheCOVID-19pandemicandahandfulofother

thingsthatbroughtthewholeideaofhealthequityandhealthdisparities

totheforefront.”

2|AcceleratingHealthEquity:ChallengesandOpportunities

Despitebroadindustryconsensusaboutthedeep

Butactioninghealthequitycanbedi?cult:

structuralhealthinequitiesinsociety,manyleadersof

healthequityfunctionswithinthelifesciencesindustry

arenowfacedwithchallengestoadvancehealth

equity—bothinternallyandexternally.Therehave

beengrowingquestionsaboutthecommercialvalue

ofinvestmentsinDEIandrequestsfordemonstration

ofevidenceofthepositiveimpactonthea?ectedill-

servedpopulations.

?Fragmentationlimitssynergy:Manycurrenthealth

equityactivitiesarefragmented,andmanytimesthe

lefthanddoesnotknowwhattherighthandisdoing.

DEIleadershavefrequentlybeensuccessfulinbuilding

synergybyconnectingseparatedepartmentsthatare

strivingtowardthesameoutcomestoimprovethe

collectivee?ortsindiversity,inclusivityinresearch,

andaccesstomedicines.

Internally,thecallforhealthequityhasbeenheard:

?DedicatedDEIfunctionswithend-to-endoversight:

Theestablishmentoffull-timededicatedDEI

leadershippositionsandteamshasbeenacritical

“Alotoftimesthelefthand

prerequisiteforadvancinghealthequitypractices

withinlifesciencescompanies.Theabilityofthese

leaderstoworkacrosstheenterprisehasbeen

importanttostimulateend-to-endhealthequity

e?ortscross-functionally.

doesn’tknowwhattherighthand

isdoing.Onepartoftheorganization

couldbepartneringwitha

?Employeeresourcegroupsareimportantdrivers:

Theemployeeresourceteamsrepresentingthe

diversegroupsthatidentifywithmarginalizedminority

populationshavebeenpositivedriversofchange.

historicallyBlackmedicalschoolon

oneinitiative,maybeingenomic

researchdiversity.Andthenclinical

Whilethecompanies’ownemployeeslikelyarenot

experiencingthesamehardshipsastheexternal

marginalizedcommunities,theyarenevertheless

researchisgoingintothesame

school,notrealizingthatgenomic

importantconduitstounderstandthespeci?cneeds

ofthesecommunitiesastheycanassesswhether

programsandinterventionsresonate.

researchisalreadyintheretalking

aboutsomethingsimilar.”

“Engagingouremployeeresourcegroupsishelpingusthinkthroughour

healthequityandsciencediversitystrategiesandapproaches.”

|3

AccHea

CHALLENG

Highlights

hostedbyt

AUGUST

2024

Tableofcontents

Participants

Introduction

Wherehave

Howdowem

Whatarethe

equityinitia

Continuedco

AbouttheIn

REFERENCINGTHISRE

Pleaseusethisformat

Source:IQVIAInstitutef

Availablefromwww.iqvi

?2024IQVIAanditsa?lia

transmittedinanyformo

expresswrittenconsento

AcceleratingHealthEquity:ChallengesandOpportunities

Participantandmoderators

SéRGIOALVES,MBA

AstraZeneca

CLEONRICE,MBA

Genentech

BINTABEARD,D.SC.,MS

Novartis

XAVIORROBINSON,MHSA

Merck

PATRICIADOYKOS,PH.D.

BristolMyersSquibb

JAYG.RONQUILLO,MD,MPH,MMSc,

MEng

P?zer

MAUREENDOYLE-SCHARFF,PH.D.

P?zer

DEBBIESMITH,PH.D.

UCB

IVYKAM,PHARMD

Regeneron

JUDITHTHOMPSON,PHARMD,MPH,

CPHQ

UCB

SHELINARAMNARINE,PH.D.

Johnson&Johnson

Moderators

MURRAYAITKEN

ExecutiveDirector,

IQVIAInstituteforHuman

DataScience

Murray.Aitken@IQVIAI

ELIZASILVESTER

SeniorPrincipal,

EnterpriseTransformationStrategy,

IQVIA

Eliza.Silvester@

|1

Introduction

Achievinghealthequityisanimportantpriorityfor

thehealthcareecosystem,especiallythelifesciences

Wherehaveweachieved

successtowardhealthequity

andhow?

industry.Theindustryhasmadedeclarationsabout

itscommitmenttoaddressdisparitiesinR&D,clinical

development,andaccesstocare,andmanyorganizations

Thehealthequitylandscapeisever-evolving,withtwo

majorin?ectionpointssince2020:

haveestablisheddedicatedteamsandfunctionsto

advancehealthequity;however,achievinghealthequity

iscomplexandchallenging,andthereisuncertainty

abouthowtomeasureanddeliversustainedprogressin

arapidlyevolving?eld.

?Aspotlightonthehealthequitylandscape:

ThepandemicandthemurderofGeorgeFloydin

2020becamein?ectionpointsforawide-ranging

movementtoaddresshealthdisparitiesand

inequitiesforvulnerableandill-servedpopulations.

Toaddressthechallengesandopportunitiesaround

Manyorganizationsandcompaniesembarkedona

healthequity,theIQVIAInstituteconvenedalifesciences

journeytoaddresstheissuesthroughcommitments

industryroundtableonApril18,2024.

anddeclarations,andmanyinvestedresourcesin

Theroundtablefocusedonthreeimportantquestions:

programsandpeople,includingthecreationofDEI

o?ces,teams,andfunctions.Successeshavebeen

?Wherehavewebeenabletoachievesuccesstoward

healthequity,andwhy?

achieved,buttherehavebeenchallengescreating

asustainableshifttowardhealthequity,both

amongintra-companyandexternalstakeholders.

?HowdowemeasuretheimpactandROIofhealth

Furthermore,therehasbeenashortageofevidence

equityinvestments?

oftheimpactofthee?orts.

?Whatarethegreatestchallenges,eitherinternalor

?BacklashagainstDEIandESG:Inthemorerecent

external,toadvancinghealthequityinitiativesandto

period,anewin?ectionpointappearstohaveemerged

addressingthesechallenges?

withagrowingbacklashtowardDEI(diversity,equity

Thefollowingsummaryprovideshighlightsfromthe

discussion.

andinclusion)andESG(environment,socialand

governance)broadlyatuniversities,ingovernments

andincorporationsaswell,inpartdrivenbythe

Thisroundtablewasconvenedasapublicservice

SupremeCourtdecisionregardinga?rmativeaction.

withoutexternalfundingandintendedtostimulate

discussionandacceleratehealthequity.

“Thein?ectionpointwastheCOVID-19pandemicandahandfulofother

thingsthatbroughtthewholeideaofhealthequityandhealthdisparities

totheforefront.”

2|AcceleratingHealthEquity:ChallengesandOpportunities

Despitebroadindustryconsensusaboutthedeep

Butactioninghealthequitycanbedi?cult:

structuralhealthinequitiesinsociety,manyleadersof

healthequityfunctionswithinthelifesciencesindustry

arenowfacedwithchallengestoadvancehealth

equity—bothinternallyandexternally.Therehave

beengrowingquestionsaboutthecommercialvalue

ofinvestmentsinDEIandrequestsfordemonstration

ofevidenceofthepositiveimpactonthea?ectedill-

servedpopulations.

?Fragmentationlimitssynergy:Manycurrenthealth

equityactivitiesarefragmented,andmanytimesthe

lefthanddoesnotknowwhattherighthandisdoing.

DEIleadershavefrequentlybeensuccessfulinbuilding

synergybyconnectingseparatedepartmentsthatare

strivingtowardthesameoutcomestoimprovethe

collectivee?ortsindiversity,inclusivityinresearch,

andaccesstomedicines.

Internally,thecallforhealthequityhasbeenheard:

?DedicatedDEIfunctionswithend-to-endoversight:

Theestablishmentoffull-timededicatedDEI

leadershippositionsandteamshasbeenacritical

“Alotoftimesthelefthand

prerequisiteforadvancinghealthequitypractices

withinlifesciencescompanies.Theabilityofthese

leaderstoworkacrosstheenterprisehasbeen

importanttostimulateend-to-endhealthequity

e?ortscross-functionally.

doesn’tknowwhattherighthand

isdoing.Onepartoftheorganization

couldbepartneringwitha

?Employeeresourcegroupsareimportantdrivers:

Theemployeeresourceteamsrepresentingthe

diversegroupsthatidentifywithmarginalizedminority

populationshavebeenpositivedriversofchange.

historicallyBlackmedicalschoolon

oneinitiative,maybeingenomic

researchdiversity.Andthenclinical

Whilethecompanies’ownemployeeslikelyarenot

experiencingthesamehardshipsastheexternal

marginalizedcommunities,theyarenevertheless

researchisgoingintothesame

school,notrealizingthatgenomic

importantconduitstounderstandthespeci?cneeds

ofthesecommunitiesastheycanassesswhether

programsandinterventionsresonate.

researchisalreadyintheretalking

aboutsomethingsimilar.”

“Engagingouremployeeresourcegroupsishelpingusthinkthroughour

healthequityandsciencediversitystrategiesandapproaches.”

|3

?Settingindustrystandardsforbrandhealthequity?Quantifyingtheimpactofbuildingnew

performance:Becauseallcompaniesarefacingthepartnerships:Oneofthechallengesistoengagewith

samechallenges,theremaybeopportunitiesforneworganizationsthatthecompanyhasnotworked

creatingcommercialstandardsforbrandperformancewithbefore,butthatareclosertothecommunitiesthe

similartoindustrystandardsfordiversityinclinicalcompanyistryingtoserve.

trials.Theparticipantsintheroundtableagreedthatindustrystandardscouldbehelpful,forexamplethroughaformofbenchmarkingbasedonagreedKPIs

thatdoesnotdisclosecon?dentialcommercialdetails.

KPIscouldincludesuchmeasuresastimetotreatment,

“Howdoyoushowrealimpact?

numberofpeoplescreened,andimprovementinhealth

systemperformance.

Impactinvolvescapacityand

infrastructuredevelopmentfor

“Wehaveindustrystandardsf

diversityinclinicaltrialsonth

side.Butwhatarethemetrics

determiningwhetherweachie

betteroutcomesforpatients,

particularpatientsthatfaceb

tocare?Howdoweshowthat

reallycanmovetheneedlein

brandperformance?”

6|AcceleratingHealthEquity:ChallengesandOppo

Whatarethegreatest

challenges,eitherinternalor

external,toadvancinghealth

equityinitiativesand

toaddressingthese?

Internally,challengeslieinenterprise-wideagreement

onhowtoproceed:

“Itisimportanttounderstandthe

untappedgrowthopportunities

throughactiononsocialdeterminants

ofhealth.Ifyoulookattheentiretyof

theHispanicandLatinopopulationin

?Gettingthebusinesstounderstand:

theUnitedStates,theeconomicpower

Participantsagreedoneofthebiggestchallengesisto

getinternalbusinessstakeholderstounderstand“the

why”behindengagingcommunitiesofcolorinhealth

ofthatgroupisbasicallythe?fth

mosteconomicallypowerfulcountry

equity-relatedinvestments.Seniorleadershipinsome

organizationsalsohesitatetomakethenecessary

investments.Thereappearstobeazero-summindset

wherethereistrade-o?betweeninvestmentsinhealth

equityversusinvestmentsinthebusiness.Thereisa

intheworld.So,there’sasigni?cant

opportunitytheretoengageinall

sortsofactivitiesthatwillallowfor

needforabetterunderstandingofhowhealthequity

canhelpadvancebusinessoutcomes.Forexample,

becauseabouthalfofallBlackindividualsintheU.S.

productloyaltyandhealthimpact.”

havecommercialhealthinsurance,thereisapotential

upsideinexpandingaccesswithinthiscommunityto

Butthereareseveralpromisingstrategicopportunities:

severaldiseasetreatments.

?Makingthecasewithdata:Therearepositive

experiencesusinginsightsanddatatod

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

最新文檔

評論

0/150

提交評論